Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1996 1
1999 1
2002 1
2004 2
2005 1
2006 1
2007 1
2008 3
2009 6
2010 8
2011 10
2012 5
2013 14
2014 16
2015 28
2016 18
2017 11
2018 11
2019 9
2020 8
2021 13
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
A review of Dengvaxia®: development to deployment.
Thomas SJ, Yoon IK. Thomas SJ, et al. Among authors: yoon ik. Hum Vaccin Immunother. 2019;15(10):2295-2314. doi: 10.1080/21645515.2019.1658503. Epub 2019 Oct 7. Hum Vaccin Immunother. 2019. PMID: 31589551 Free PMC article. Review.
Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue.
Utarini A, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Ansari MR, Supriyati E, Wardana DS, Meitika Y, Ernesia I, Nurhayati I, Prabowo E, Andari B, Green BR, Hodgson L, Cutcher Z, Rancès E, Ryan PA, O'Neill SL, Dufault SM, Tanamas SK, Jewell NP, Anders KL, Simmons CP; AWED Study Group. Utarini A, et al. N Engl J Med. 2021 Jun 10;384(23):2177-2186. doi: 10.1056/NEJMoa2030243. N Engl J Med. 2021. PMID: 34107180 Free PMC article. Clinical Trial.
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M; CYD-TDV Dengue Vaccine Working Group. Hadinegoro SR, et al. N Engl J Med. 2015 Sep 24;373(13):1195-206. doi: 10.1056/NEJMoa1506223. Epub 2015 Jul 27. N Engl J Med. 2015. PMID: 26214039 Free article. Clinical Trial.
Immune correlates for dengue vaccine development.
Srikiatkhachorn A, Yoon IK. Srikiatkhachorn A, et al. Among authors: yoon ik. Expert Rev Vaccines. 2016;15(4):455-65. doi: 10.1586/14760584.2016.1116949. Epub 2015 Nov 24. Expert Rev Vaccines. 2016. PMID: 26560015 Free PMC article. Review.
An Update on Zika Virus in Asia.
Lim SK, Lim JK, Yoon IK. Lim SK, et al. Among authors: yoon ik. Infect Chemother. 2017 Jun;49(2):91-100. doi: 10.3947/ic.2017.49.2.91. Infect Chemother. 2017. PMID: 28681575 Free PMC article. Review.
Prospects for dengue vaccines for travelers.
Lim SK, Lee YS, Namkung S, Lim JK, Yoon IK. Lim SK, et al. Among authors: yoon ik. Clin Exp Vaccine Res. 2016 Jul;5(2):89-100. doi: 10.7774/cevr.2016.5.2.89. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489798 Free PMC article. Review.
Edging closer towards the goal of a dengue vaccine.
Wilder-Smith A, Yoon IK. Wilder-Smith A, et al. Among authors: yoon ik. Expert Rev Vaccines. 2016;15(4):433-5. doi: 10.1586/14760584.2016.1154459. Expert Rev Vaccines. 2016. PMID: 26881780 No abstract available.
Capacity-building efforts by the AFHSC-GEIS program.
Sanchez JL, Johns MC, Burke RL, Vest KG, Fukuda MM, Yoon IK, Lon C, Quintana M, Schnabel DC, Pimentel G, Mansour M, Tobias S, Montgomery JM, Gray GC, Saylors K, Ndip LM, Lewis S, Blair PJ, Sjoberg PA, Kuschner RA, Russell KL, Blazes DL; AFHSC-GEIS Capacity Building Writing Group; Witt CJ, Money NN, Gaydos JC, Pavlin JA, Gibbons RV, Jarman RG, Stoner M, Shrestha SK, Owens AB, Iioshi N, Osuna MA, Martin SK, Gordon SW, Bulimo WD, Waitumbi DJ, Assefa B, Tjaden JA, Earhart KC, Kasper MR, Brice GT, Rogers WO, Kochel T, Laguna-Torres VA, Garcia J, Baker W, Wolfe N, Tamoufe U, Djoko CF, Fair JN, Akoachere JF, Feighner B, Hawksworth A, Myers CA, Courtney WG, Macintosh VA, Gibbons T, Macias EA, Grogl M, O'Neil MT, Lyons AG, Houng HS, Rueda L, Mattero A, Sekonde E, Sang R, Sang W, Palys TJ, Jerke KH, Millard M, Erima B, Mimbe D, Byarugaba D, Wabwire-Mangen F, Shiau D, Wells N, Bacon D, Misinzo G, Kulanga C, Haverkamp G, Kohi YM, Brown ML, Klein TA, Meyers M, Schoepp RJ, Norwood DA, Cooper MJ, Maza JP, Reeves WE, Guan J. Sanchez JL, et al. Among authors: yoon ik. BMC Public Health. 2011 Mar 4;11 Suppl 2(Suppl 2):S4. doi: 10.1186/1471-2458-11-S2-S4. BMC Public Health. 2011. PMID: 21388564 Free PMC article. Review.
The mRNA vaccine development landscape for infectious diseases.
Kumar A, Blum J, Thanh Le T, Havelange N, Magini D, Yoon IK. Kumar A, et al. Among authors: yoon ik. Nat Rev Drug Discov. 2022 May;21(5):333-334. doi: 10.1038/d41573-022-00035-z. Nat Rev Drug Discov. 2022. PMID: 35149859 No abstract available.
154 results